Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Merck
Mallinckrodt
Citi
Chubb
Daiichi Sankyo
Colorcon
Cantor Fitzgerald
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,863,004

« Back to Dashboard

Summary for Patent: 3,863,004
Title: DENATURED MACROPROTEIN WITH DIVALENT TIN FOR TAGGING WITH TECHNETIUM-99M AND METHOD OF PREPARATION
Abstract:An improved composition suitable for tagging with technetium-99m and use in lung scanning procedures consists essentially of an injectable suspension in buffer solution of particles of a denatured macroprotein having divalent tin bound thereto. The macroprotein has a molecular weight of at least about 20,000. A method for preparing the injectable suspension by treating macroaggregates or microspheres of a denatured macroprotein with a solution containing divalent tin ions is also provided.
Inventor(s): Wolfangel; Robert G. (St. Louis, MO)
Assignee: Mallinckroft Chemical Works (St. Louis, MO)
Application Number:05/236,159
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process;

Drugs Protected by US Patent 3,863,004

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 3,863,004

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 472255 ➤ Subscribe
Australia 5337573 ➤ Subscribe
Belgium 796962 ➤ Subscribe
Germany 2314059 ➤ Subscribe
France 2182880 ➤ Subscribe
United Kingdom 1409176 ➤ Subscribe
Israel 41767 ➤ Subscribe
Italy 989625 ➤ Subscribe
Japan S4954517 ➤ Subscribe
Japan S5328971 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
UBS
Farmers Insurance
Merck
Dow
Chubb
Daiichi Sankyo
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot